Diagnosis and treatment of a patient with severe hepatitis and rash caused by toripalimab: A case report
This case proposes that clinician should comprehensively determine the risk of adverse reactions and strengthen medication monitoring to ensure patient safety.
Authors
- Liping Dai
- Ting Jiang (ORCID: https://orcid.org/0000-0002-4392-5631)
- Wei Guo (ORCID: https://orcid.org/0000-0002-3615-7128)
- Yeyao Li
- Jing Li (ORCID: https://orcid.org/0009-0006-4535-3207)
- Ya Jia (ORCID: https://orcid.org/0000-0002-2818-9074)
Institutions
- Chengdu Medical College (CN)
- Fourth People's Hospital of Sichuan Province (CN)
- First Affiliated Hospital of Chengdu Medical College (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1097/md.0000000000044122
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05